reglab/housing_qa huggingface dataset:
32 ME Rev Stat § 13764 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 7: SERVICES AT RURAL HEALTH CENTERS|32 §13764. Rules

 §13764. Rules The board shall adopt rules in conformity with the Maine Administrative Procedure Act, Title 5, chapter 375, to carry out the purposes of this subchapter.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13771 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 8: THIRD-PARTY PRESCRIPTION PROGRAM ACT|32 §13771. Short title

 §13771. Short title This subchapter shall be known and may be cited as the "Third-party Prescription Program Act."   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13772 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 8: THIRD-PARTY PRESCRIPTION PROGRAM ACT|32 §13772. Definitions

 §13772. Definitions As used in this subchapter, unless the context otherwise indicates, the following terms have the following meanings.   [PL 1987, c. 710, §5 (NEW).]1.  Third-party prescription program.  "Third-party prescription program" means any system of providing for the reimbursement of pharmaceutical goods and services under a contractual arrangement or agreement between a provider of goods and services and another party who is not the consumer of those goods and services. These programs include, but are not limited to, insurance plans which provide coverage for prescription drugs or other pharmaceutical services.   [PL 1987, c. 710, §5 (NEW).] SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13773 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 8: THIRD-PARTY PRESCRIPTION PROGRAM ACT|32 §13773. Notice

 §13773. Notice A 3rd-party prescription program may not be instituted in this State until the program provider has filed written notice of the provisions of the program with the Superintendent of Insurance and the board and given written notice to all pharmacies that are located within the counties covered by the program at least 30 days prior to the commencement of the program. In the case of chain or branch pharmacies, the notice must be given to the main office or headquarters. These pharmacies have 30 days from the date of notice to enroll in the program.   [PL 1997, c. 245, §12 (AMD).]SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 1989, c. 720, §1 (AMD). PL 1997, c. 245, §12 (AMD).
32 ME Rev Stat § 13774 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 8: THIRD-PARTY PRESCRIPTION PROGRAM ACT|32 §13774. Denial of payment

 §13774. Denial of payment No program administrator may deny to any pharmacy payment for services which may have resulted from the fraudulent or illegal use of an identification card by any person, unless the pharmacy has been notified that the card has been canceled or discontinued and that the program administrator has been unsuccessful in attempting to regain possession of the card.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13775 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 8: THIRD-PARTY PRESCRIPTION PROGRAM ACT|32 §13775. Reimbursement rates

 §13775. Reimbursement rates A 3rd-party prescription program is prohibited from charging a pharmacy a registration fee or other fixed charge, either annually or otherwise, except in cases where a charge is necessary to specifically cover any equipment, forms or materials required by the program.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13776 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 8: THIRD-PARTY PRESCRIPTION PROGRAM ACT|32 §13776. Contract renewal and changes

 §13776. Contract renewal and changes Any changes in benefits or provisions in any contract may not be made unilaterally by either the program administrator or the pharmacy. Any change in a contract offered to one pharmacy shall be offered to all the state pharmacies participating in the program.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13777 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 8: THIRD-PARTY PRESCRIPTION PROGRAM ACT|32 §13777. Exceptions

 §13777. Exceptions This Act does not apply to any medical assistance or public health programs administered by the Department of Health and Human Services, including, but not limited to, the Medicaid program and the Low Cost Drug Program; to any employee benefit plan that is subject to the Employee Retirement Income Security Act of 1974, 29 United States Code, Section 1001, et seq.; and to any 3rd-party prescription programs administered in accordance with and subject to the limitations of the former Nonprofit Service Organizations Preferred Provider Arrangement Act of 1985, Title 24, chapter 19, subchapter II, or the Preferred Provider Arrangement Act, Title 24‑A, chapter 32.   [PL 1999, c. 790, Pt. A, §39 (AMD); PL 2003, c. 689, Pt. B, §6 (REV).]SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 1989, c. 720, §2 (AMD). PL 1999, c. 790, §A39 (AMD). PL 2003, c. 689, §B6 (REV).
32 ME Rev Stat § 13782 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13782. Advertising

 §13782. Advertising It is lawful for any pharmacy, pharmacist or other licensee of the board to advertise to the public the current retail price charged for any drugs, medicines or appliances as defined in the United States Code, Title 21, Section 3211 (g) (1) which bears the legend "Caution: Federal law prohibits dispensing without prescription." The advertising may be according to either the brand name or the generic name of the drug. No media advertising of any drugs included in the United States Comprehensive Drug Abuse Prevention and Control Act of 1970, 84 Stat. 1236, is permitted.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13782-A (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13782-A. Price disclosure

 §13782-A. Price disclosure 1.  Price disclosure required.  A pharmacist or pharmacy technician employed by a pharmacy shall disclose upon the request of any person making an inquiry in person or by telephone the price of any brand or generic drug sold by that pharmacy.   [PL 2007, c. 402, Pt. DD, §30 (AMD).] 2.  Information required for price disclosure.  In order to have sufficient information to disclose a prescription price, a pharmacist or pharmacy technician may ask the person making the inquiry for the following information:   A. The brand or generic name of the medication;   [PL 1997, c. 245, §15 (NEW).]B. The dose or strength of the medication, if applicable; or   [PL 1997, c. 245, §15 (NEW).]C. The quantity of the medication.   [PL 1997, c. 245, §15 (NEW).][PL 1997, c. 245, §15 (NEW).] 3.  Information not provided.  If the inquiring person can not provide some or all of the information in subsection 2 and this information is necessary for the requested price to be determined, then the pharmacist or pharmacy technician may contact the prescribing practitioner in order to obtain the necessary information prior to disclosing the prescription price.   [PL 1997, c. 245, §15 (NEW).] SECTION HISTORY PL 1997, c. 245, §15 (NEW). PL 2007, c. 402, Pt. DD, §30 (AMD).
32 ME Rev Stat § 13783 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13783. Posting prices (REPEALED)

 §13783. Posting prices (REPEALED)SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 1997, c. 245, §16 (RP).
32 ME Rev Stat § 13784 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13784. Patient information regulation

 §13784. Patient information regulation 1.  Explanation by pharmacist.  With each new prescription dispensed, the pharmacist, in addition to labeling the prescription in accordance with the requirements of the State, must orally explain to the patient or the patient's agent the directions for use and any additional information, in writing if necessary, to assure the proper utilization of the medication or device prescribed. For those prescriptions delivered outside the confines of the pharmacy, the explanation shall be by telephone or in writing. This section does not apply to those prescriptions for patients in hospitals or institutions where the medication is to be administered by a nurse or other individual licensed to administer medications or to those prescriptions for patients who are to be discharged from a hospital or institution.   [PL 1987, c. 710, §5 (NEW).] 2.  Maintenance of current reference material.  To ensure that proper information is available to each pharmacist, each pharmacy or pharmacist shall maintain current reference material on drug interactions.   [PL 1987, c. 710, §5 (NEW).] 3.  Retail price.  With each prescription dispensed, the pharmacist shall disclose to the patient in writing the usual and customary price of the prescription and the cost of any payment toward the price required of the patient.   [RR 2003, c. 2, §120 (AFF); PL 2003, c. 375, §1 (NEW).] SECTION HISTORY PL 1987, c. 710, §5 (NEW). RR 2003, c. 2, §120 (AFF). PL 2003, c. 375, §1 (AMD). PL 2003, c. 375, §2 (AFF).
32 ME Rev Stat § 13785 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13785. Patient profile record system regulation

 §13785. Patient profile record system regulation A patient profile record system shall be maintained in all pharmacies for persons for whom prescriptions are dispensed. The patient profile record system shall be devised to enable the immediate retrieval of information necessary for the dispensing pharmacist to identify previously dispensed medication at the time a prescription is presented for dispensing. One profile record or document may be maintained for all members of a family living at the same address and possessing the same family name. The following information shall be recorded:   [PL 1987, c. 710, §5 (NEW).]1.  Name.  The family name and the first name of the person for whom the medication is intended;   [PL 1987, c. 710, §5 (NEW).] 2.  Address.  The address to correspond to the name in subsection 1;   [PL 1987, c. 710, §5 (NEW).] 3.  Age group.  An indication of the patient's age group, that is, infant, child or adult;   [PL 1987, c. 710, §5 (NEW).] 4.  Original date of dispensing.  The original date the medication is dispensed pursuant to the receipt of a practitioner's prescription;   [PL 1987, c. 710, §5 (NEW).] 5.  Prescription identification.  The number or designation identifying the prescription;   [PL 1987, c. 710, §5 (NEW).] 6.  Prescriber's name.  The name of the person prescribing the drug or device;   [PL 1987, c. 710, §5 (NEW).] 7.  Drug information.  The name, strength and quantity of the drug; and   [PL 1987, c. 710, §5 (NEW).] 8.  Initials of pharmacist; date of refill.  The initials of the dispensing pharmacist and the date of dispensing the medication as a renewal or refill, if those initials and that date are not recorded on the back of the original prescription.   [PL 1987, c. 710, §5 (NEW).] The pharmacist shall attempt to ascertain and shall record any allergies and idiosyncrasies of the patient and any chronic conditions which may relate to drug utilization as communicated to the pharmacy by the patient.   [PL 1987, c. 710, §5 (NEW).]Upon receipt of a prescription, a pharmacist shall examine the patient's profile record before dispensing the medication to determine the possibility of a harmful drug interaction or reaction. Upon recognizing a potentially harmful reaction or interaction, the pharmacist shall take appropriate action to avoid or minimize the problem which may include consultation with the practitioner.   [PL 1987, c. 710, §5 (NEW).]A patient profile record must be maintained for a period of not less than the amount of time required under federal Medicare laws, beginning from the date of the last entry in the profile record. As used in this section, "Medicare" means the Health Insurance for the Aged Act, Title XVIII of the Social Security Amendments of 1965, as amended.   [PL 1999, c. 130, §13 (AMD).]SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 1999, c. 130, §13 (AMD).
32 ME Rev Stat § 13786 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13786. Identification of persons prescribing medicines on hospital prescription blanks

 §13786. Identification of persons prescribing medicines on hospital prescription blanks Any practitioner who writes a prescription upon a prescription blank of a hospital or clinic shall sign that practitioner's name and cause that name to be printed, stamped or typed on the blank.   [PL 1987, c. 710, §5 (NEW).]This section applies to any registered nurse who writes a prescription while working under the control or supervision of a physician. The name of the physician under whom the nurse works must be printed, stamped or typed on the blank.   [PL 2019, c. 627, Pt. B, §19 (AMD).]SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 2019, c. 627, Pt. B, §19 (AMD).
32 ME Rev Stat § 13786-B (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13786-B. Partial dispensing of prescription for opioid medication

 §13786-B. Partial dispensing of prescription for opioid medication 1.  Partial dispensing authorized.  Notwithstanding any law or rule to the contrary, a pharmacist may partially dispense a prescription for an opioid medication in a lesser quantity than the recommended full quantity indicated on the prescription if requested by the patient for whom the prescription is written. The remaining quantity of the prescription in excess of the recommended full quantity is void and may not be dispensed without a new prescription.   [PL 2015, c. 488, §30 (NEW).] 2.  Notice to practitioner.  If a pharmacist partially dispenses a prescription for an opioid medication as permitted under this section, the pharmacist or the pharmacist's designee shall, within a reasonable time following the partial dispensing but not more than 7 days, notify the practitioner of the quantity of the opioid medication actually dispensed. The notice may be conveyed by a notation on the patient's electronic health record or by electronic transmission, by facsimile or by telephone to the practitioner.   [PL 2015, c. 488, §30 (NEW).] SECTION HISTORY PL 2015, c. 488, §30 (NEW).
32 ME Rev Stat § 13786-C (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13786-C. Dispensing of prescription of opioid medication; immunity

 §13786-C. Dispensing of prescription of opioid medication; immunity A pharmacist who dispenses opioid medication in good faith is immune from any civil liability that might otherwise result from dispensing medication in excess of the limit established in section 2210, subsection 1, paragraphs A and B; section 2600‑C, subsection 1, paragraphs A and B; section 3300‑F, subsection 1, paragraphs A and B; section 3657, subsection 1, paragraphs A and B; or section 18308, subsection 1, paragraphs A and B, if the medication was dispensed in accordance with a prescription issued by a practitioner. In a proceeding regarding immunity from liability, there is a rebuttable presumption of good faith.   [PL 2015, c. 488, §31 (NEW).]SECTION HISTORY PL 2015, c. 488, §31 (NEW).
32 ME Rev Stat § 13786-D (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13786-D. Prescribing and dispensing insulin

 §13786-D. Prescribing and dispensing insulin 1.  Definitions.  As used in this section, unless the context otherwise indicates, the following terms have the following meanings.   A. "Insulin" includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation.   [PL 2019, c. 666, Pt. B, §1 (NEW).]B. "Insulin-related devices and supplies" means needles, syringes, cartridge systems, prefilled pen systems, glucose meters and test strips. "Insulin-related devices and supplies" does not include insulin pump devices.   [PL 2019, c. 666, Pt. B, §1 (NEW).][PL 2019, c. 666, Pt. B, §1 (NEW).] 2.  Authorization.  As authorized by the board in accordance with rules adopted under subsection 3, a pharmacist may dispense emergency refills of insulin and associated insulin-related devices and supplies by prescription drug order or standing order or pursuant to a collaborative practice agreement authorizing insulin to be dispensed. The insulin dispensed under this subsection must be in a quantity that is at least a 30-day supply unless the intended recipient requests a lesser quantity upon consultation with the pharmacist. The intended recipient shall provide evidence of a previous prescription from a practitioner and attest that a refill of that previous prescription may not be readily or easily obtained under the circumstances. Upon receiving evidence of a previous prescription from a practitioner, the pharmacist shall immediately notify that practitioner that an emergency refill of insulin was dispensed and instruct the recipient to seek follow-up care from the practitioner as soon as possible.   [PL 2021, c. 20, §1 (AMD).] 3.  Rules; protocols.  The board by rule shall establish standards for authorizing pharmacists to dispense insulin in accordance with subsection 2, including protocols for notifying practitioners when emergency refills of insulin are dispensed. Rules adopted under this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A.   [PL 2021, c. 20, §2 (AMD).] SECTION HISTORY PL 2019, c. 666, Pt. B, §1 (NEW). PL 2021, c. 20, §§1, 2 (AMD).
32 ME Rev Stat § 13787 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13787. Hypodermic syringes; prescriptions (REPEALED)

 §13787. Hypodermic syringes; prescriptions (REPEALED)SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 1993, c. 394, §1 (RP).
32 ME Rev Stat § 13787-A (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13787-A. Sale of hypodermic apparatus

 §13787-A. Sale of hypodermic apparatus 1.  Authorized seller.  A hypodermic apparatus, as defined in Title 17‑A, section 1101, subsection 2, may be sold only by a manufacturer or dealer of embalming supplies, manufacturer or dealer of medical or dental supplies, wholesale druggist, manufacturing pharmacist, pharmacist, veterinarian, agricultural supply store or manufacturer of surgical instruments.   [PL 1993, c. 394, §2 (NEW).] 2.  Purchaser.  Any person who is 18 years of age or older may purchase a hypodermic apparatus from a seller described in subsection 1.   [PL 1993, c. 394, §2 (NEW).] 3.  Criminal immunity.   [PL 2021, c. 434, §12 (RP).] 4.  Immunity limited.  This section does not limit prosecution for violation of any law prohibiting or regulating the use, possession, dispensing, distribution or promotion of controlled substances or scheduled drugs.   [PL 2021, c. 434, §13 (AMD).] 5.  Medicaid not affected.  This section does not diminish, expand or otherwise affect Medicaid reimbursement for hypodermic apparatuses.   [PL 1993, c. 394, §2 (NEW).] SECTION HISTORY PL 1993, c. 394, §2 (NEW). PL 2003, c. 688, §A39 (AMD). PL 2021, c. 434, §§12, 13 (AMD).
32 ME Rev Stat § 13788 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13788. Sale of poisonous drugs

 §13788. Sale of poisonous drugs Each licensed pharmacist who sells a poison shall affix to the package sold a label plainly marked with the name and address of the store and the word "POISON" and the name of the poison sold, and shall enter at the time of sale in a permanently bound book to be kept for that purpose the name and address of the purchaser, the date of sale, the name of the poison and the quantity sold and the person making the sale shall sign the entry. This section shall not apply to sales on prescription of practitioners, sales at wholesale to pharmacists or sales to hospitals, colleges or public institutions.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13789 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13789. Possession of drug samples

 §13789. Possession of drug samples No person may purchase manufacturers' drug samples from any person for purposes of resale. If those samples are given gratuitously to a licensed pharmacist, qualified assistant pharmacist or medical practitioner, any such sample may be given to any person, as long as the sample is kept in containers suitably labeled to conform to the Federal Food and Drug Act and the state food and drug laws and this gift is subject to the laws relating to the sale of drugs.   [PL 2007, c. 402, Pt. DD, §31 (AMD).]SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 2007, c. 402, Pt. DD, §31 (AMD).
32 ME Rev Stat § 13790 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13790. Using drugs not in prescription

 §13790. Using drugs not in prescription If a pharmacist knowingly uses any drugs or ingredients in preparing or compounding a written or oral prescription of any practitioner different from those named in the prescription, that use shall constitute a civil violation for which a forfeiture of not more than $1,000 nor less than $50 may be adjudged.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13791 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13791. Return of drugs

 §13791. Return of drugs A drug or pharmaceutical preparation that has been dispensed on prescription may be returned to pharmacy stock after being in possession and under the control of another person and may be dispensed again if the drug is packaged in an unbroken, sealed container or if, in the case of a hospital, a licensed pharmacist determines that the drug has not been impaired.   [PL 1993, c. 231, §1 (AMD).]SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 1993, c. 231, §1 (AMD).